Fig. 2.

Schematic to show the hypothesised mechanisms by which mitochondrial DNA mutations may become manifest in tumours and either inhibit or promote tumour growth and/or progression. WT mtDNA is depicted in blue. Mutated mtDNA molecules conferring an advantageous metabolic phenotype for tumour growth are shown in green, and those causing a detrimental metabolic phenotype are shown in red